BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 38 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q1 2019. The put-call ratio across all filers is 9.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,201 | -80.6% | 6,000 | +100.0% | 0.00% | -100.0% |
Q2 2023 | $6,180 | -37.6% | 3,000 | 0.0% | 0.00% | -50.0% |
Q1 2023 | $9,900 | +101.2% | 3,000 | 0.0% | 0.00% | +100.0% |
Q4 2022 | $4,920 | -62.2% | 3,000 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $13,000 | +62.5% | 3,000 | 0.0% | 0.00% | +100.0% |
Q2 2022 | $8,000 | -20.0% | 3,000 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $10,000 | -16.7% | 3,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $12,000 | +20.0% | 3,000 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $10,000 | -9.1% | 3,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $11,000 | +37.5% | 3,000 | +50.0% | 0.00% | 0.0% |
Q1 2021 | $8,000 | -11.1% | 2,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $9,000 | -73.5% | 2,000 | 0.0% | 0.00% | -75.0% |
Q3 2020 | $34,000 | +54.5% | 2,000 | 0.0% | 0.01% | +60.0% |
Q2 2020 | $22,000 | +144.4% | 2,000 | 0.0% | 0.01% | +150.0% |
Q1 2020 | $9,000 | 0.0% | 2,000 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $9,000 | +12.5% | 2,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $8,000 | 0.0% | 2,000 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $8,000 | -11.1% | 2,000 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $9,000 | +28.6% | 2,000 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $7,000 | -12.5% | 2,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $8,000 | 0.0% | 2,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $8,000 | +33.3% | 2,000 | 0.0% | 0.00% | +100.0% |
Q1 2018 | $6,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 242,850 | $923,000 | 0.13% |
ABNER HERRMAN & BROCK LLC | 241,500 | $918,000 | 0.13% |
Weaver Consulting Group | 48,881 | $186,000 | 0.10% |
Tibra Equities Europe Ltd | 87,000 | $331,000 | 0.10% |
Ikarian Capital, LLC | 293,200 | $1,115,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 60,238 | $229,000 | 0.03% |
Ergoteles LLC | 124,329 | $472,000 | 0.01% |
CFO4Life Group, LLC | 12,003 | $46,000 | 0.01% |
HighPoint Advisor Group LLC | 17,033 | $65,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 32,836 | $125,000 | 0.00% |